Miniaturized CAR knocked onto CD3ε extends TCR function with CAR specificity under control of endogenous TCR signaling cascade
Katrin Manske(Technical University of Munich), Mateusz P. Poltorak(Otto-von-Guericke-Universität Magdeburg), Lisa Dreßler(Bristol-Myers Squibb (Germany)), Vlad Cletiu(Bristol-Myers Squibb (Germany)), Claudia Tschulik(Bristol-Myers Squibb (Germany)), Manuel Effenberger(Institute of Medical Microbiology and Hygiene), Dirk H. Busch(German Center for Infection Research), Thomas Müller(Johns Hopkins University), Christian Stemberger(Juno Therapeutics (Germany)), Michaela Wagner(Bristol-Myers Squibb (Germany)), Simon P. Fräßle(Bristol-Myers Squibb (Germany)), Kilian Schober(Friedrich-Alexander-Universität Erlangen-Nürnberg), Lothar Germeroth, Eileen Benke(Bristol-Myers Squibb (Germany))
Cited by 8
Related Papers
Randomized Phase III Trial of Pemetrexed Versus Docetaxel in Patients With Non–Small-Cell Lung Cancer Previously Treated With Chemotherapy
|Journal of Clinical Oncology|2004|2.4k
Guidelines for the use of flow cytometry and cell sorting in immunological studies (second edition)
|European Journal of Immunology|2019|1k
Direct identification of clinically relevant neoepitopes presented on native human melanoma tissue by mass spectrometry
|Nature Communications|2016|727
Guidelines for the use of flow cytometry and cell sorting in immunological studies <sup>*</sup>
|European Journal of Immunology|2017|554
Activity of XL184 (Cabozantinib), an Oral Tyrosine Kinase Inhibitor, in Patients With Medullary Thyroid Cancer
|Journal of Clinical Oncology|2011|551